Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02028273 · ClinicalTrials.gov registry record
Hippocampal Neurogenesis in Human Subjects
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 14
- Enrollment target
NCT02028273: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT02028273 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 14 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02028273 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
Study Summary
This study is being done to measure the number of brain cells that grow in the brain throughout our lives while determining an effective way to complete this with an MRI (Magnetic Resonance Imaging) scanner. The number of these brain cells may be affected by cocaine use. Researchers are trying to understand the long-term effects of cocaine use on the brain.
Primary Outcome
A 1 hour Magnetic Resonance Spectroscopy to determine the presence of newborn hippocampal neurons in using and abstinent cocaine addicts
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2012-05 |
| Est. Completion | 2018-01 |
What the finished NCT02028273 record still lists
NCT02028273 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 14 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02028273 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02028273 about?
NCT02028273 is a clinical study titled "Hippocampal Neurogenesis in Human Subjects". This study is being done to measure the number of brain cells that grow in the brain throughout our lives while determining an effective way to complete this with an MRI (Magnetic Resonance Imaging) scanner. The number of these brain cells may be affected by cocaine use. Researchers are trying to un...
What is the current status of trial NCT02028273?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2012-05. Estimated completion is 2018-01.
Who is sponsoring clinical trial NCT02028273?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia